Triamcinolone Acetonide Intravitreal Injection
Last Updated: November 28, 2022
Status: Current
Products Affected - Description
-
- Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
Reason for the Shortage
-
- Novartis did not provide a reason for the shortage.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Novartis has Triesence 40 mg/mL 1 mL vials on back order and the company estimates a release date of 2nd quarter 2023.
Updated
Updated November 28, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.